Contributors from the PKU community discuss the implications of redefining ‘unmet medical need’ in the EU’s pharmaceutical ...

Warrier sees the fundamental reason of failure as the lack of alignment between stakeholders - clinical, technical, ...

A new hemp definition in Congress' spending bill is reigniting debate over legal cannabis and setting up a fight over CBD and ...

In the Continuing Resolution and Appropriations Package (H.R. 5371), enacted into law on November 12, 2025, Congress included several new ...

The Orphan Drug Act has catalyzed innovation in rare disease treatments, but the law’s shortcomings — particularly around ...

The spending bill that ended the government shutdown threatens hemp products and led to confusion around marijuana legality.

Florida Rep. Michelle Salzman, a Republican from Pensacola, has filed a bill for consideration in 2026 that would aim to help ...

In-house design and manufacturing of key components, combined with an integrated AI workflow, for a cohesive MRI experience.

FDA approves daratumumab for high-risk smoldering multiple myeloma, transforming treatment strategies and enhancing patient outcomes in early intervention.

A federal health agency plans to soon authorize health insurance coverage for CBD under certain Medicare programs. The policy ...

Drugmakers claim that broad state PFAS laws are overly burdensome. But environmental health experts aren’t convinced.

Drs Kathy Miller and Bonnie Ky discuss cardiovascular concerns with HER2-targeted therapies and how to work with cardiology ...